menu
    • menu

    Company profile for Triplet Therapeutics

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are developing a fundamentally different treatment for repeat expansion disorders — including Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias — by addressing the underlying cause of the genetic dysfunction that drives disease onset and progression. To accomplish this goal, we’ve assembled a team with decades of expertise across drug discovery, genetics, clinical research and operations. We’r...
    We are developing a fundamentally different treatment for repeat expansion disorders — including Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias — by addressing the underlying cause of the genetic dysfunction that drives disease onset and progression. To accomplish this goal, we’ve assembled a team with decades of expertise across drug discovery, genetics, clinical research and operations. We’re supported by a top-tier syndicate of investors who share our commitment to transforming the lives of patients and families affected by repeat expansion disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Triplet TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Kendall Square 1400W, Suite 14201 Cambridge, MA 02139
    Telephone
    Telephone
    781.299.7830
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.triplettx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/triplet-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/TripletThera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Triplet focused on Huntington's disease shuts down in less than 3 years
    Triplet focused on Huntington's disease shuts down in less than 3 years

    12 Oct 2022

    // Max Gelman ENDPTS

    https://endpts.com/atlas-backed-biotech-focused-on-huntingtons-disease-shuts-down-less-than-three-years-after-launch/

    Max Gelman ENDPTS
    12 Oct 2022
    Share Share
    Triplet Presents Preclinical Data for TTX-3360, Announces Equity Pledge
    Triplet Presents Preclinical Data for TTX-3360, Announces Equity Pledge

    28 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210427006117/en/Triplet-Therapeutics-Presents-Preclinical-Data-for-TTX-3360-Announces-Equity-Pledge-at-the-CHDI-Foundation%E2%80%99s-16th-Annual-HD-Therapeutics-Conference

    BUSINESSWIRE
    28 Apr 2021
    Share Share
    Triplet Presents Preclinical Data for TTX-3360, Equity Pledge at the CHDI
    Triplet Presents Preclinical Data for TTX-3360, Equity Pledge at the CHDI

    27 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210427006117/en

    BUSINESSWIRE
    27 Apr 2021
    Share Share
    Triplet & three other startups got venture funding a year ago. Where they now?
    Triplet & three other startups got venture funding a year ago. Where they now?

    05 Jan 2021

    // Kate Sheridan STATNEWS

    https://www.statnews.com/2021/01/05/something-ventured-q4-2019/

    Kate Sheridan STATNEWS
    05 Jan 2021
    Share Share
    Triplet Therapeutics Announces Participation in Natural History Study
    Triplet Therapeutics Announces Participation in Natural History Study

    17 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200818005129/en

    BUSINESSWIRE
    17 Aug 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search